516 RANDOMIZED CONTROLLED TRIAL OF PROPHYLACTIC ENTECAVIR IN HBSAG-NEGATIVE/ANTI-HBC-POSITIVE LYMPHOMA PATIENTS UNDERGOING RITUXIMAB-BASED CHEMOTHERAPY: PRELIMINARY REPORT
2012
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI